Gainesville-based developer Concept Companies has completed construction on a new 12,950-square-foot office and lab building in Copeland Park for UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company.
With its official move-in date on July 27, 2020, Lacerta Therapeutics is the newest tenant in Alachua’s Copeland Park. Strategically located in the heart of the University of Florida, Greater Gainesville and Alachua’s Research Cluster, Copeland Park offers state-of-the-art, build-to-suit laboratory and office space for biotechnology and life science companies.
Dr. Joe Reddy, president and chief executive officer of Lacerta Therapeutics, said, “Thanks to Brian Crawford and his team for delivering Lacerta’s customized facility in a timely manner, despite challenges due to COVID-19. This custom-built facility enables us to expand our team and continue our mission to make AAV-based therapies available for all patients with rare and serious neurological disorders. Soon, we plan to build a manufacturing facility on the adjoining lot to commercialize our proprietary, scalable OneBac AAV manufacturing platform.”Learn more about Concept Companies Unveils New Office for Lacerta Therapeutics in Alachua’s Copeland Park.
Related news New Location for Lacerta Therapeutics in Alachua’s Copeland Park.